The psychosocial impact of the COVID‐19 pandemic on patients with monoclonal gammopathy of undermined significance, smouldering and active myeloma: findings from an international survey-Reference-Cited by-同舟云学术

The psychosocial impact of the COVID‐19 pandemic on patients with monoclonal gammopathy of undermined significance, smouldering and active myeloma: findings from an international survey

Published:2021-06-21 Issue:2 Volume:194 Page:294-297
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Quinn Stephen J.¹^ORCID,Anderson Lesley A.²,Lohfeld Lynne¹,McShane Charlene M.¹^ORCID

Affiliation:

1. Centre for Public Health Queen's University Belfast BelfastUK

2. Aberdeen Centre for Health Data Science University of Aberdeen Aberdeen UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17427

Reference10 articles.

1. National Health Service UK.Who's at higher risk from coronavirus.2020. Available at:https://www.nhs.uk/conditions/coronavirus‐covid‐19/people‐at‐higher‐risk/whos‐at‐higher‐risk‐from‐coronavirus/. Accessed: 22 November 2021.

2. A case series of Monoclonal Gammopathy of Undetermined Significance and COVID‐19

3. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

4. World Health Organisation.WHOQOL‐BREF: Introduction administration scoring and generic version of the assessment: field trial version December 1996. Geneva;1996. (Programme on Mental Health).

5. EuroQol Research Foundation.EQ‐5D‐5L User Guide.2019.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychological toxicity in classical hematology;European Journal of Haematology;2023-07-17

2. Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study;Haematologica;2021-11-04

3. COVID symptoms, testing, shielding impact on patient reported outcomes and early vaccine responses in individuals with multiple myeloma;2021-05-22